| Industry: | Venture Capital & Private Equity |
| Revenues: | $1.5 Million |
| Employees: | 12 |
| Monthly Unique Visitors: |
255
|
| Site Rank: |
3,080,514
|
| Trust Rating: |
Neutral
|
Stats
by ![]() |
|
| LaVoie Group Adds Cardioxyl Pharmaceuticals to Its Client Roster. PR Newswire; 8/6/2009 ...currently in clinical development for ADHF. Cardioxyl is financed by leading life science venture investors, including the Aurora Funds and New Enterprise Associates. For more information, please visit http://www.cardioxyl.com/. About LaVoie... ...more |
| Metastatix Targeting CXCR4 Receptors In Cancer, HIV. BIOWORLD Today; 11/3/2009 ...State of Georgia. Those existing investors also participated in the Series A. Other Series A investors included: The Aurora Funds, of Durham, N.C.; CM Capital, of Brisbane, Australia; SR One, of West Conshohocken, Pa.; and MedImmune... ...more |
| No Shocker: VCs Remain Product-Focused Investors. BIOWORLD Today; 11/3/2009 ...director of H.I.G. Ventures, advised entrepreneurs to be more "scrappy," and Chris Kroeger, a principal with The Aurora Funds, urged a certain craftiness. Look to standard angel or friends and family investors, panelists said, as well as... ...more |
![]() |
Add New Company | Add Your Profile | Tools & Resources | Developer API | Sales & Marketing Blog
FAQ | Privacy Policy | Terms of Service | About Us | Contact Us | Jobs at ZoomInfo
Copyright © 2009 Zoom Information Inc. All rights reserved.
BBeachHead-2009-12-03_RC001.1 OM11